These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Monoamine oxidase inhibitor dietary restrictions: what are we asking patients to give up? Sweet RA; Brown EJ; Heimberg RG; Ciafre L; Scanga DM; Cornelius JR; Dube S; Forsyth KM; Holt CS J Clin Psychiatry; 1995 May; 56(5):196-201. PubMed ID: 7737959 [TBL] [Abstract][Full Text] [Related]
4. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. Rapaport MH J Clin Psychiatry; 2007; 68 Suppl 8():42-6. PubMed ID: 17640157 [TBL] [Abstract][Full Text] [Related]
5. The transdermal delivery system of monoamine oxidase inhibitors. VanDenBerg CM J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239 [TBL] [Abstract][Full Text] [Related]
6. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults. Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903 [TBL] [Abstract][Full Text] [Related]
7. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. Flockhart DA J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238 [TBL] [Abstract][Full Text] [Related]
9. The making of a user friendly MAOI diet. Gardner DM; Shulman KI; Walker SE; Tailor SA J Clin Psychiatry; 1996 Mar; 57(3):99-104. PubMed ID: 8617704 [TBL] [Abstract][Full Text] [Related]
10. Dietary restriction, tyramine, and the use of monoamine oxidase inhibitors. Shulman KI; Walker SE; MacKenzie S; Knowles S J Clin Psychopharmacol; 1989 Dec; 9(6):397-402. PubMed ID: 2592589 [TBL] [Abstract][Full Text] [Related]
11. The monoamine oxidase inhibitor-tyramine interaction. Brown C; Taniguchi G; Yip K J Clin Pharmacol; 1989 Jun; 29(6):529-32. PubMed ID: 2666453 [TBL] [Abstract][Full Text] [Related]
12. The use of monoamine oxidase inhibitors in primary care. Culpepper L J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241 [TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase inhibitors: safety and efficacy issues. Brown CS; Bryant SG Drug Intell Clin Pharm; 1988 Mar; 22(3):232-5. PubMed ID: 3284731 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Thomas SJ; Shin M; McInnis MG; Bostwick JR Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531 [TBL] [Abstract][Full Text] [Related]
16. The role of monoamine oxidase inhibitors in current psychiatric practice. Fiedorowicz JG; Swartz KL J Psychiatr Pract; 2004 Jul; 10(4):239-48. PubMed ID: 15552546 [TBL] [Abstract][Full Text] [Related]
17. Tyramine studies and the safety of MAOI drugs. Simpson GM; White K J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):59-61. PubMed ID: 6735997 [TBL] [Abstract][Full Text] [Related]
18. Diet and monoamine oxidase inhibitors: a re-examination. Sullivan EA; Shulman KI Can J Psychiatry; 1984 Dec; 29(8):707-11. PubMed ID: 6394124 [TBL] [Abstract][Full Text] [Related]